About Activities

Activities Index

  • Standards for Systematic Reviews of Comparative Effectiveness Research Consensus Study
    An ad hoc committee will conduct a study to recommend methodologic standards for systematic reviews of clinical effectiveness research on health and health care.
  • Cancer Clinical Trials and the NCI Cooperative Group Program Consensus Study
    This IOM committee is reviewing the organization and operation of the National Cancer Institute (NCI) Cooperative Group Program and working on recommending ways to improve the quality of cancer clinical trials conducted by the Groups.
  • Ranking FDA Product Categories Based on Health Consequences, Phase I Consensus Study
    An expert committee will develop and apply an evidence-based conceptual model and methods to rank product categories within the broad types of products addressed by programs of the U.S. Food and Drug Administration (FDA).
  • Studies of U.S. Veteran Twins Epidemiological Study
    In 1958, the Medical Follow-up Agency began a project to identify white male twins who had jointly entered military service during World War II. In the end, MFUA identified nearly 16,000 twin pairs in which both members had served in the military.
  • Sequel to Assessment of Future Scientific Needs for Live Variola Virus Consensus Study
    An IOM committee will perform a comprehensive evaluation of the research and development work recommended in that report and completed to date, and consider what unmet needs still exist that require the use of live variola virus.
  • Certification of Personal Protective Technologies Consensus Study
    The Committee on the Certification of Personal Protective Technologies will assess the certification mechanisms needed to ensure the efficacy of nonrespirator personal protective technologies (PPT).
  • Accelerating Rare Diseases Research and Orphan Product Development Consensus Study
    In response to a request from the NIH Office of Rare Diseases and the FDA Office of Orphan Products Development, a committee of the IOM will prepare a report that will assess existing strategies to promote research discoveries and development of...
  • Review of Adverse Effects of Vaccines Consensus Study
    The committee will review the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the Vaccine Injury Compensation Program.
  • Ranking FDA Product Categories Based on Health Consequences, Phase II Consensus Study
    An expert committee will refine and apply an evidence-based conceptual model to rank product categories within the broad types of products addressed by programs of the U.S. Food and Drug Administration (FDA).
  • Comparative Effectiveness Research Prioritization Consensus Study
    An ad hoc committee will conduct a study to recommend national priorities for comparative effectiveness research to be conducted or supported with funds from the American Recovery and Reinvestment Act of 2009.